» Articles » PMID: 36289746

Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict Up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma Patients

Overview
Journal Biomedicines
Date 2022 Oct 27
PMID 36289746
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To study whether the density of tumor-infiltrating T lymphocytes and tumor-infiltrating macrophages predicted general 20-year overall survival (OS), as well as OS with only disease-specific survival (DSS) patients included.

Methods: Biopsies from patients treated for OPSCC ( = 180) were stained by immunohistochemistry and the tumor cell macrophage (CD68), pan T lymphocytes (CD3), and regulatory T lymphocytes (Foxp3) densities were determined. The HE-determined percentage of matured tumor cells and the rate of invasion were calculated, and stromal desmoplasia were performed. Tumor HPV presence was studied by PCR. Twenty-year OS and five-year DSS patients were determined.

Results: Tumor HPV status strongly predicted survival. High tumor infiltration of CD3, Foxp3 and CD68-positive cells predicted better twenty-year OS, with and without HPV stratification. Foxp3 and CD68 levels predicted OS, and 20-year among DSS patients, primarily among HPV(+) patients. Tumor HE-derived variables did not predict such survival.

Conclusions: Tumor HPV status, level of Foxp3 tumor-infiltrating lymphocytes and CD68 tumor-infiltrating macrophages predicted up to 20-year OS of both all patients and disease-specific survived patients.

Citing Articles

Effects of macrophages in OSCC progression.

Dong X, Dong C, Li B Front Immunol. 2025; 15:1517886.

PMID: 39877372 PMC: 11772471. DOI: 10.3389/fimmu.2024.1517886.


Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review.

Li Y, Zhang C, Jiang A, Lin A, Liu Z, Cheng X J Transl Med. 2024; 22(1):293.

PMID: 38509593 PMC: 10953261. DOI: 10.1186/s12967-024-05104-y.


De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: evolving paradigms and future strategies.

Chen A Front Oncol. 2023; 13:1175578.

PMID: 37576899 PMC: 10413127. DOI: 10.3389/fonc.2023.1175578.


Circulating CD137 T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.

Cirillo A, Zizzari I, Botticelli A, Strigari L, Rahimi H, Scagnoli S Int J Mol Sci. 2023; 24(8).

PMID: 37108276 PMC: 10138766. DOI: 10.3390/ijms24087114.

References
1.
Linette G, Carreno B . Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era. Curr Hematol Malig Rep. 2019; 14(4):286-291. PMC: 6642683. DOI: 10.1007/s11899-019-00523-x. View

2.
Lippitz B, Harris R . Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016; 5(5):e1093722. PMC: 4910721. DOI: 10.1080/2162402X.2015.1093722. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Aarstad H, Aarstad H, Vintermyr O, Kross K, Lybak S, Heimdal J . In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients. Scand J Immunol. 2016; 85(3):211-219. DOI: 10.1111/sji.12518. View

5.
Aye L, Song X, Yang J, Hu L, Sun X, Zhou J . Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol. 2021; 9:695533. PMC: 8381651. DOI: 10.3389/fcell.2021.695533. View